Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Vanda Pharmaceuticals Inc. (VNDA)

Pharmaceutical Preparations

https://www.vandapharma.com

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include VHX-896 and ASO Molecules. The majority of revenue is derived from HETLIOZ product sales.

2200 PENNSYLVANIA AVE NW, SUITE 300E
WASHINGTON, DC

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/12/2006

Market Cap

300,775,368

Shares Outstanding

57,530,000

Weighted SO

57,531,999

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

BMRN --.--%

PCVX --.--%

LQDA --.--%

LEGN --.--%

TECH --.--%

NUVB --.--%

TIL --.--%

CNTB --.--%

NLTX --.--%

Beta

0.7500

Last Div

0.0000

Range

3.3-6.75

Chg

-0.0100

Avg Vol

1009135

Mkt Cap

300775368

Exch

NASDAQ

Country

US

Phone

202 734 3400

DCF Diff

-10.0205

DCF

15.1706

Div Yield

0.0000

P/S

1.6524

EV Multiple

-7.7133

P/FV

0.5538

Div Yield %

0.0000

P/E

-27.4933

PEG

0.4561

Payout

0.0000

Current Ratio

4.6825

Quick Ratio

4.6669

Cash Ratio

1.0977

DSO

83.9479

DIO

32.5632

Op Cycle

116.5110

DPO

83.7022

CCC

32.8089

Gross Margin

0.9095

Op Margin

-0.1784

Pretax Margin

-0.0657

Net Margin

-0.0600

Eff Tax Rate

0.0864

ROA

-0.0168

ROE

-0.0201

ROCE

-0.0582

NI/EBT

0.9136

EBT/EBIT

0.3684

EBIT/Rev

-0.1784

Debt Ratio

0.0129

D/E

0.0155

LT Debt/Cap

0.0109

Total Debt/Cap

0.0153

Int Coverage

-9.2140

CF/Debt

-0.6098

Equity Multi

1.2006

Rec Turnover

4.3479

Pay Turnover

4.3607

Inv Turnover

11.2090

FA Turnover

20.9751

Asset Turnover

0.2794

OCF/Share

-0.0883

FCF/Share

-0.0950

Cash/Share

6.6587

OCF/Sales

-0.0282

FCF/OCF

1.0762

CF Coverage

-0.6098

ST Coverage

-2.1191

CapEx Coverage

-13.1148

Div&CapEx Cov

-13.1148

P/BV

0.5538

P/B

0.5538

P/S

1.6524

P/E

-27.4933

P/FCF

-54.3603

P/OCF

-58.4360

P/CF

-58.4360

PEG

0.4561

P/S

1.6524

EV Multiple

-7.7133

P/FV

0.5538

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation